Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
for
Leukemia, Lymphoma, Multiple Myeloma,
Location: Omaha NE
Sponsor: University of Nebraska
Sex: All
Age: 19+
Code: NCT04898790
Recruiting
Prehabilitation Feasibility Among Older Adults Undergoing Transplantation
for
Multiple Myeloma
Location: Birmingham AL
Sponsor: Noha Mohamed Sharafeldin
Sex: All
Age: 60+
Code: NCT05642884
Recruiting
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
for
Monoclonal Gammopathy of Undetermined Significance,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT05640843
Recruiting
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
for
Non Hodgkin Lymphoma, Richter Transformation, Multiple Myeloma,
Location: Boston MA, Chapel Hill NC, Columbus OH, Cincinnati OH,
Sponsor: Newave Pharmaceutical Inc
Sex: All
Age: 13+
Code: NCT04771572
Phase1, Recruiting
Interested in new multiple sclerosis trials?
Get alerts for new trials in your area by subscribing now
LMY-920 for Treatment of Relapsed or Refractory Myeloma
for
Multiple Myeloma, Refractory, Multiple Myeloma in Relapse
Location: Cleveland OH
Sponsor: Luminary Therapeutics
Sex: All
Age: 18+
Code: NCT05546723
Phase1, Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
for
Relapsed/Refractory Multiple Myeloma
Location: Boston MA, The Bronx NY, Chapel Hill NC, Atlanta GA,
Sponsor: Ichnos Sciences SA
Sex: All
Age: 18+
Code: NCT05862012
Phase1, Recruiting
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
for
Myeloma Multiple
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05091372
Phase2, Recruiting
Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment